Purchase Order 36C25624P0787
- Not listed
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the provision of Novocure's Optune Plus Transducers, a cancer therapy product utilizing Tumor Treating Fields (TTFields) technology. The contract does not have a set-aside designation and is part of Novocure's 5-year, $28.85 million Federal...
- This is a firm fixed price purchase order from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit company, to provide its Optune electrical field therapy transducers and related rental and support services. The contract, with a potential value of $105,000.00, has a completion date of September 30, 2020 and was awarded on May 1, 2020. The order is to deliver Novocure's Optune tumor treating fields (TTFields) therapy...
- This is a firm-fixed-price purchase order awarded to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract has a ceiling value of $16,582.91 and a performance period ending on October 9, 2024. The award is for Optune Plus Transducer, part of Novocure's proprietary Optune system that delivers Tumor Treating Fields (TTFields) therapy for the treatment of glioblastoma and other...
- This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the delivery of Optune Plus Transducers, which are part of Novocure's Optune system, a non-invasive cancer therapy technology that utilizes Tumor Treating Fields (TTFields) to disrupt solid tumor cancer cell division. The contract is not set aside and is part of a larger $28.85...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit company, to provide Optune Plus Transducers. The order has a potential value of $49,748.73 and a completion date of May 31, 2024. This order is part of a larger 5-year Federal Supply Schedule (FSS) contract with the VA VHA valued at up to $28.85 million, which allows the VA to efficiently procure Novocure's Optune tumor...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit company. The contract has a potential value of $99,173.46 and is to provide Novocure's Optune tumor treating fields (TTFields) therapy devices, transducers, rentals, and support services to VA medical centers and facilities nationwide. Novocure holds a 5-year Federal Supply Schedule (FSS) contract with the VA VHA, valued at...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit oncology company. The contract is for the rental of Novocure's Optune Transducer devices, which use tumor treating fields (TTFields) therapy to disrupt solid tumor cancer cell division. The contract has a potential value of $16,582.91 and a completion date of May 30, 2024. Novocure is the prime contractor and...
- This is a firm fixed price purchase order issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit organization, to provide its Optune transducer medical device and related equipment, rentals, and support services. The $49,748.73 contract has a completion date of July 19, 2024 and was awarded on April 19, 2024. Novocure holds a 5-year $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA to provide medical...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $21,000.00, is for the delivery of Novocure's Optune Plus Transducers, which are part of the company's Optune system for delivering Tumor Treating Fields (TTFields) therapy to treat solid tumor cancers, including glioblastoma and mesothelioma. This contract is not...
- This is a purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the delivery of Novocure's Optune Plus Transducers, an FDA-approved cancer therapy device that uses Tumor Treating Fields (TTFields) technology. The contract has a firm fixed price of $49,748.73 and a period of performance through October 31, 2024. The contract does not...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit organization specializing in cancer therapy with Tumor Treating Fields (TTFields). The contract is to provide Novocure's Optune PLUS transducers, a medical device that delivers therapeutic alternating electric fields to disrupt solid tumor cancer cell division. The contract has a completion date of September 27, 2024 and a potential value of $49,748.73. This award is not set aside. Novocure holds a 5-year Federal Supply Schedule (FSS) contract valued up to $28.85 million with the VA VHA to provide its Optune line of TTFields therapy devices, transducer arrays, rental equipment, and associated support services. Under this FSS contract, various VA Integrated Service Networks (VISNs) have placed delivery orders to Novocure to procure Optune products and support for distribution to VA medical centers treating veterans with forms of solid tumor cancer like glioblastoma.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.7k | 3/27/24 |